Your browser doesn't support javascript.
loading
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
Gupta, Rishi K; Calderwood, Claire J; Yavlinsky, Alexei; Krutikov, Maria; Quartagno, Matteo; Aichelburg, Maximilian C; Altet, Neus; Diel, Roland; Dobler, Claudia C; Dominguez, Jose; Doyle, Joseph S; Erkens, Connie; Geis, Steffen; Haldar, Pranabashis; Hauri, Anja M; Hermansen, Thomas; Johnston, James C; Lange, Christoph; Lange, Berit; van Leth, Frank; Muñoz, Laura; Roder, Christine; Romanowski, Kamila; Roth, David; Sester, Martina; Sloot, Rosa; Sotgiu, Giovanni; Woltmann, Gerrit; Yoshiyama, Takashi; Zellweger, Jean-Pierre; Zenner, Dominik; Aldridge, Robert W; Copas, Andrew; Rangaka, Molebogeng X; Lipman, Marc; Noursadeghi, Mahdad; Abubakar, Ibrahim.
Afiliação
  • Gupta RK; Institute for Global Health, University College London, London, UK.
  • Calderwood CJ; Institute for Global Health, University College London, London, UK.
  • Yavlinsky A; Institute of Health Informatics, University College London, London, UK.
  • Krutikov M; Institute for Global Health, University College London, London, UK.
  • Quartagno M; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Aichelburg MC; Department of Dermatology, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria.
  • Altet N; Unitat de Tuberculosis, Hospital Universitari Vall d'Hebron-Drassanes, Barcelona, Spain.
  • Diel R; Unitat de TDO de la Tuberculosis 'Servicios Clínicos', Barcelona, Spain.
  • Dobler CC; Institute for Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Dominguez J; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Großhansdorf, Germany.
  • Doyle JS; Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia.
  • Erkens C; Department of Respiratory Medicine, Liverpool Hospital, Sydney, Australia.
  • Geis S; Institut d'Investigació Germans Trias i Pujol, Badalona, Barcelona, Spain.
  • Haldar P; CIBER Enfermedades Respiratorias, Badalona, Barcelona, Spain.
  • Hauri AM; Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.
  • Hermansen T; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Australia.
  • Johnston JC; Disease Elimination Program, Burnet Institute, Melbourne, Australia.
  • Lange C; KNCV Tuberculosis Foundation, The Hague, The Netherlands.
  • Lange B; Institute for Medical Microbiology and Hospital Hygiene, Philipps University of Marburg, Marburg, Germany.
  • van Leth F; Respiratory Biomedical Research Centre, Institute for Lung Health, Department of Respiratory Sciences, University of Leicester, Leicester, UK.
  • Muñoz L; Hesse State Health Office, Dillenburg, Germany.
  • Roder C; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
  • Romanowski K; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Roth D; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
  • Sester M; German Center for Infection Research (DZIF), Clinical Tuberculosis Center, Borstel, Germany.
  • Sloot R; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.
  • Sotgiu G; Department of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Woltmann G; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Yoshiyama T; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.
  • Zellweger JP; Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
  • Zenner D; Department of Global Health, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
  • Aldridge RW; Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
  • Copas A; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Australia.
  • Rangaka MX; Disease Elimination Program, Burnet Institute, Melbourne, Australia.
  • Lipman M; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Noursadeghi M; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Abubakar I; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.
Nat Med ; 26(12): 1941-1949, 2020 12.
Article em En | MEDLINE | ID: mdl-33077958
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Tuberculose / Tuberculose Latente / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Tuberculose / Tuberculose Latente / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido